Profile
Jason S.
Kim worked as the Director of Business Development at ImClone LLC from 2003 to 2006.
He then served as the Director of Business & Corporate Development at OSI Pharmaceuticals, Inc. from 2009 to 2011.
Jason also worked as an Associate at Safeguard Scientifics, Inc. and Domain Associates LLC.
From 2010 to 2017, he held the position of President & Chief Financial Officer at Molecular Templates, Inc. In 2023, he became the President, CFO, CAO & Treasurer at Molecular Templates, Inc. Jason also served as the Chief Operating Officer at Molecular Templates OpCo, Inc. Mr. Kim completed his undergraduate studies at Wesleyan University and earned an MBA from The Wharton School of the University of Pennsylvania.
Former positions of Jason Kim
| Companies | Position | End |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Director of Finance/CFO | 08/12/2024 |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Director of Finance/CFO | 01/08/2017 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2011 |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Corporate Officer/Principal | 01/01/2009 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 01/01/2006 |
Training of Jason Kim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Safeguard Scientifics, Inc.
Safeguard Scientifics, Inc. Investment ManagersFinance Invests in technology companies | Finance |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Finance |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
- Stock Market
- Insiders
- Jason Kim
















